Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites

NCT06677333 · View on ClinicalTrials.gov ↗

Study Summary

This study will determine the effect of dietary protein not absorbed in the small intestine on the bacteria in the large intestine and the metabolites those bacteria produce when they break down the protein. The three specific goals are: 1. Determine if increasing dietary protein increases the purine breakdown product, allantoin, as observed in our previous study. 2. Establish a model to examine the effect of dietary protein on the gut microbiota and metabolites. 3. Identify gut bacteria and metabolite changes that occur with increased consumption of animal (whey) or plant (pea) protein sources.

Conditions Studied

Interventions

  • OTHER Whey Protein
  • OTHER Pea protein

Study Locations (1)

Louisiana

  • Louisiana State University Health Sciences Center New Orleans — New Orleans

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2023-02-01
Est. Completion 2023-11-30
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06677333

The ClinicalTrials.gov registry entry for NCT06677333 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Louisiana State University Health Sciences Center in New Orleans, which has 13 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Health Adults appearing as the primary indexed condition, and to 2 interventions — of which Whey Protein is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06677333 reports 1 study location spanning 1 distinct geographic area — top geographies include Louisiana. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06677333 about?

NCT06677333 is a clinical study titled "The Effect of Increasing Dietary Protein on the Gut Microbiome and Its Metabolites". This study will determine the effect of dietary protein not absorbed in the small intestine on the bacteria in the large intestine and the metabolites those bacteria produce when they break down the protein. The three specific goals are: 1. Determine if increasing dietary protein increases the puri...

What is the current status of trial NCT06677333?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2023-02-01. Estimated completion is 2023-11-30.

What conditions does trial NCT06677333 study?

This clinical trial studies the following conditions: Health Adults. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06677333?

The interventions under investigation include: Whey Protein (OTHER), Pea protein (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06677333?

This trial is sponsored by Louisiana State University Health Sciences Center in New Orleans, which has 13 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06677333 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial